Addressing Iron deficiency anemia in Bangladesh

Anemia, a condition marked by reduced red blood cell or hemoglobin levels, affects over 1.92 billion people globally, with a particularly high prevalence in Bangladesh. This condition impedes oxygen delivery, leading to fatigue, weakness, and diminished physical productivity, contributing to economic challenges, especially in developing regions. Iron supplementation remains central to anemia management, yet traditional iron salts, such as ferrous sulfate and ferrous fumarate, often result in gastrointestinal discomfort, limiting patient adherence. Ferric citrate, with its improved bioavailability, enhanced gastrointestinal tolerance, and stability across varying pH levels, represents a promising alternative. Furthermore, ferric citrate offers additional benefits, such as reducing serum phosphate levels and binding uremic toxins, making it advantageous for populations with kidney disease and for pregnant women who require safer iron supplementation

Anemia, defined as a deficiency in red blood cells or hemoglobin, remains a significant public health issue worldwide, impacting both individual health and economic productivity. It is estimated that around one-third of the global population suffers from anemia, making it one of the most prevalent health conditions [1,2]. Anemia affects the body’s ability to transport oxygen, leading to symptoms such as fatigue, weakness, and reduced physical and mental capacity. Severe cases can result in complications like cardiovascular strain, shortness of breath, and even loss of consciousness [3]. The condition can also manifest in physical signs like pallor, cool skin, and tachypnoea, while specific indicators like jaundice, glossitis, and cheilitis can suggest underlying causes such as hemolysis or deficiencies in iron and vitamins. [2,4] The condition not only undermines individual well-being but also reduces workforce efficiency, thereby hampering economic growth, particularly in developing countries